Development and validation of the Cambridge Multimorbidity Score

Area of Science:

• Health Services Research
• Epidemiology
• Biostatistics

Background:

• Health services struggle to manage the complexities of multimorbidity.
• There's a critical need for better multimorbidity measures in research and resource allocation.
• Existing tools like the Charlson Comorbidity Index have limitations.

Purpose of the Study:

• To develop and validate a novel multimorbidity score.
• To assess its predictive performance for key healthcare outcomes.
• To compare its efficacy against the Charlson Comorbidity Index.

Main Methods:

• Modeled associations between 37 morbidities and 3 outcomes (consultations, admissions, death) at 1 and 5 years.
• Utilized large UK Clinical Practice Research Datalink development (n=300,000) and validation (n=150,000) datasets.
• Constructed a general-outcome multimorbidity score and compared it with the Charlson Comorbidity Index.

Main Results:

• The developed models demonstrated acceptable predictive ability for consultations (C-index 0.732), admissions (0.742), and death (0.912) at 1 year.
• Reduced models (20 conditions) showed similar predictive performance.
• The new score significantly outperformed the Charlson Comorbidity Index for consultations and admissions.

Conclusions:

• The Cambridge Multimorbidity Score is a robust and valuable tool.
• It can be tailored or untailored for specific health outcomes.
• It will aid service planning, resource allocation, and multimorbidity research.